Diabetes and prognosis in a breast cancer cohort

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 6, 2011, Pages 975-983

  Schrauder, Michael G ^a   Fasching, Peter A ^b   Häberle, Lothar ^a   Lux, Michael P ^a   Rauh, Claudia ^a   Hein, Alexander ^a   Bayer, Christian M ^a   Heusinger, Katharina ^a   Hartmann, Arndt ^a   Strehl, Johanna D ^a   Wachter, David L ^a   Schulz Wendtland, Rüdiger ^a   Adamietz, Boris ^a   Beckmann, Matthias W ^a   Loehberg, Christian R ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; Cohort study; Diabetes mellitus; Distant metastasis; Local recurrence; Survival

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGED; AGING; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TUMOR VOLUME;

ADULT; AGED; BODY MASS INDEX; BREAST NEOPLASMS; COHORT STUDIES; DIABETES COMPLICATIONS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RECEPTORS, ESTROGEN; RETROSPECTIVE STUDIES;

EID: 79959713962     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-010-0960-2     Document Type: Article

References (38)

1. Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL, Wolff AC, Brancati FL (2008) Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: A systematic review and meta-analysis. JAMA 300(23):2754-2764. doi:10.1001/jama.2008.824
2. Blamey RW, Cataliotti L (2006) Eusoma accreditation of breast units. Eur J Cancer 42(10):1331-1337. doi:10.1016/j.ejca.2006.04.003 (Pubitemid 43903163)
3. Bray GA (1985) Obesity: definition, diagnosis and disadvantages. Med J Aust 142(7 Suppl):S2-S8
4. Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4(8):579-591. doi:10.1038/nrc1408 (Pubitemid 39025053)
5. Cardoso F, Castiglione M (2009) Locally recurrent or metastatic breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 20(Suppl 4):15-18. doi:10.1093/annonc/mdp115
6. Chlebowski RT, Blackburn GL, Buzzard IM, Rose DP, Martino S, Khandekar JD, York RM, Jeffery RW, Elashoff RM, Wynder EL (1993) Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The women's intervention nutrition study. J Clin Oncol 11(11):2072-2080 (Pubitemid 23332242)
7. Chlebowski RT, Blackburn GL, Thomson CA, Nixon DW, Shapiro A, Hoy MK, Goodman MT, Giuliano AE, Karanja N, McAndrew P, Hudis C, Butler J, Merkel D, Kristal A, Caan B, Michaelson R, Vinciguerra V, Del Prete S, Winkler M, Hall R, Simon M, Winters BL, Elashoff RM (2006) Dietary fat reduction and breast cancer outcome: Interim efficacy results from the women's intervention nutrition study. J Natl Cancer Inst 98(24):1767-1776. doi:10.1093/jnci/djj494 (Pubitemid 46017928)
8. Chlebowski RT, Anderson G, Pettinger M, Lane D, Langer RD, Gilligan MA, Walsh BW, Chen C, McTiernan A (2008) Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy. Arch Intern Med 168(4):370-377. doi:10.1001/archinternmed.2007.123 (quiz 345) (Pubitemid 351347128)
9. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of us adults. Am J Epidemiol 159(12):1160-1167. doi:10.1093/aje/kwh161.159/12/1160 (Pubitemid 38747263)
10. Daling JR, Malone KE, Doody DR, Johnson LG, Gralow JR, Porter PL (2001) Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer 92(4):720-729. doi:10.1002/1097-0142 (20010815)92:4〈720::AID-CNCR1375〉3.0.CO;2-T
11. Del Giudice ME, Fantus IG, Ezzat S, McKeown-Eyssen G, Page D, Goodwin PJ (1998) Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res Treat 47(2):111-120 (Pubitemid 28046082)
12. Eng-Wong J, Perkins SN, Bondy M, Li D, Eva Singletary S, Nunez N, Hursting S, Chang S (2009) Premenopausal breast cancer: estrogen receptor status and insulin-like growth factor-i (igf-i), insulin-like growth factor binding protein-3 (igfbp-3), and leptin. Breast J 15(4):426-428. doi:10.1111/j.1524- 4741.2009.00753.x
13. Feng YH, Velazquez-Torres G, Gully C, Chen J, Lee MH, Yeung SC (2010) The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth. J Cell Mol Med. doi:10.1111/j.1582-4934.2010.01083.x
14. Goodwin PJ, Boyd NF (1990) Body size and breast cancer prognosis: a critical review of the evidence. Breast Cancer Res Treat 16(3):205-214
15. Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Madarnas Y, Hartwick W, Hoffman B, Hood N (2002) Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20(1):42-51 (Pubitemid 34032594)
16. Grambsch PM, Therneau TM (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81(3):515-526. doi:10.1093/biomet/81.3.515
17. Grote VA, Becker S, Kaaks R (2010) Diabetes mellitus type 2 - an independent risk factor for cancer? Exp Clin Endocrinol Diabetes 118(1):4-8. doi:10.1055/s-0029-1243193
18. Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Li J, Ho GY, Xue X, Anderson GL, Kaplan RC, Harris TG, Howard BV, Wylie-Rosett J, Burk RD, Strickler HD (2009) Insulin, insulin-like growth factor-i, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 101(1):48-60. doi:10.1093/jnci/djn415
19. Hjalgrim H, Frisch M, Ekbom A, Kyvik KO, Melbye M, Green A (1997) Cancer and diabetes - a follow-up study of two population-based cohorts of diabetic patients. J Intern Med 241(6):471-475 (Pubitemid 27315827)
20. Jiralerspong S, Palla SL, Giordano SH, Meric-Bernstam F, Liedtke C, Barnett CM, Hsu L, Hung MC, Hortobagyi GN, Gonzalez-Angulo AM (2009) Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol 27(20):3297-3302. doi:10.1200/JCO. 2009.19.6410
21. Kelsey JL, Berkowitz GS (1988) Breast cancer epidemiology. Cancer Res 48(20):5615-5623
22. Kleinberg DL, Wood TL, Furth PA, Lee AV (2009) Growth hormone and insulin-like growth factor-i in the transition from normal mammary development to preneoplastic mammary lesions. Endocr Rev 30(1):51-74. doi:10.1210/er.2008- 0022
23. Larsson SC, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 121(4):856-862. doi:10.1002/ijc.22717 (Pubitemid 47106217)
24. LeRoith D, Novosyadlyy R, Gallagher EJ, Lann D, Vijayakumar A, Yakar S (2008) Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence. Exp Clin Endocrinol Diabetes 116(Suppl 1):S4-S6. doi:10.1055/s-2008- 1081488
25. Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE (2008) The impact of diabetes on survival following breast cancer. Breast Cancer Res Treat 109(2):389-395. doi:10.1007/s10549-007-9654-0 (Pubitemid 351644852)
26. Michels KB, Solomon CG, Hu FB, Rosner BA, Hankinson SE, Colditz GA, Manson JE (2003) Type 2 diabetes and subsequent incidence of breast cancer in the nurses' health study. Diabetes Care 26(6):1752-1758 (Pubitemid 36929115)
27. Patterson RE, Flatt SW, Saquib N, Rock CL, Caan BJ, Parker BA, Laughlin GA, Erickson K, Thomson CA, Bardwell WA, Hajek RA, Pierce JP (2010) Medical comorbidities predict mortality in women with a history of early stage breast cancer. Breast Cancer Res Treat. doi:10.1007/s10549-010-0732-3
28. Richardson LC, Pollack LA (2005) Therapy insight: Influence of type 2 diabetes on the development, treatment and outcomes of cancer. Nat Clin Pract Oncol 2(1):48-53. doi:10.1038/ncponc0062 (Pubitemid 40823181)
29. Rose DP, Vona-Davis L (2009) Influence of obesity on breast cancer receptor status and prognosis. Expert Rev Anticancer Ther 9(8):1091-1101. doi:10.1586/era.09.71
30. Rose DP, Vona-Davis L (2010) Interaction between menopausal status and obesity in affecting breast cancer risk. Maturitas 66(1):33-38. doi:10.1016/j.maturitas.2010.01.019
31. Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, Borgen PI, Clark G, Edge SB, Hayes DF, Hughes LL, Hutter RV, Morrow M, Page DL, Recht A, Theriault RL, Thor A, Weaver DL, Wieand HS, Greene FL (2002) Revision of the American Joint Committee on Cancer Staging System for Breast Cancer. J Clin Oncol 20(17):3628-3636
32. Stephenson GD, Rose DP (2003) Breast cancer and obesity: an update. Nutr Cancer 45(1):1-16 (Pubitemid 36736886)
33. Tsugane S, Inoue M (2010) Insulin resistance and cancer: epidemiological evidence. Cancer Sci. doi:10.1111/j.1349-7006.2010.01521.x
34. Ursin G, Longnecker MP, Haile RW, Greenland S (1995) A meta-analysis of body mass index and risk of premenopausal breast cancer. Epidemiology 6(2):137-141
35. Verlato G, Zoppini G, Bonora E, Muggeo M (2003) Mortality from site-specific malignancies in type 2 diabetic patients from Verona. Diabetes Care 26(4):1047-1051 (Pubitemid 36929246)
36. Vona-Davis L, Howard-McNatt M, Rose DP (2007) Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer. Obes Rev 8(5):395-408. doi:10.1111/j.1467-789X.2007.00396.x (Pubitemid 47283945)
37. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000, projections for 2030. Diabetes Care 27(5):1047-1053 (Pubitemid 38579764)
38. Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B (2005) Diabetes mellitus and breast cancer. Lancet Oncol 6(2):103-111. doi:10.1016/S1470- 2045(05)01736-5 (Pubitemid 40197704)